We also propose optimized filgrastim treatment for three scenarios: for BEACOPP escalated, we predict that starting 1 day earlier and increasing the number of G-CSF injections would result in improved leukopenia prophylaxis. This evidence concerns the gene CSF3 and Decreased total leukocyte count.